ALTEOGEN Inc. (196170.KQ)
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
308,500.00+0.10%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-26.9%
The outlook
ALTEOGEN Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 18% of the way from its 52-week low to high, avg target +48% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range18% of the way from its 52-week low to high
Price targetAvg target +48% vs current price
Analyst price target
~12-month · 5 analysts458,000.00average target+48.5% vs now
Now 308,500.00
Low 250,000.00High 620,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$16.51T
52-wk high
569,000.00
52-wk low
253,000.00
50-day avg
333,210.00
200-day avg
401,677.50
Trailing P/E
—